RMED Key Statistics, Chart & Performance
The current stock price of RMED is 0.594 USD. In the past month the price decreased by -13.28%. In the past year, price decreased by -92.68%.
RMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About RMED
Company Profile
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
Company Info
RA MEDICAL SYSTEMS INC
1670 Highway 160 West, Suite 205
Fort Mill SOUTH CAROLINA 92011 US
CEO: Jonathan Will McGuire
Employees: 14
Phone: 19736912000.0
RA MEDICAL SYSTEMS INC / RMED FAQ
Can you describe the business of RA MEDICAL SYSTEMS INC?
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
What is the current price of RMED stock?
The current stock price of RMED is 0.594 USD. The price increased by 10% in the last trading session.
Does RA MEDICAL SYSTEMS INC pay dividends?
RMED does not pay a dividend.
What is the ChartMill rating of RA MEDICAL SYSTEMS INC stock?
RMED has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is RMED stock listed?
RMED stock is listed on the NYSE Arca exchange.
What is the GICS sector and industry of RMED stock?
RA MEDICAL SYSTEMS INC (RMED) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
RMED Technical Analysis
RMED Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RMED. The financial health of RMED is average, but there are quite some concerns on its profitability.
RMED Financial Highlights
Over the last trailing twelve months RMED reported a non-GAAP Earnings per Share(EPS) of -45.97. The EPS increased by 73.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
RMED Forecast & Estimates
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
For the next year, analysts expect an EPS growth of 52.85% and a revenue growth 13964.3% for RMED